WinterGreen Research announces that it has published a new study
Oxygen Concentrators: Market Shares, Strategy, and Forecasts, Worldwide, 2013
to 2019. The 2013 study has 572 pages, 241 tables and figures. Worldwide
markets are poised to achieve continuing growth as the aging population
worldwide needs homecare oxygen treatment. Older people develop COPD and other
respiratory conditions where oxygen is able to improve the quality of the life
in a dramatic manner. Portable devices have become affordable and support a
mobile lifestyle even while on oxygen.
To Read The Complete Report with TOC :-
There has been a quantum improvement in the portable oxygen
concentrator technology. Less weight, more power are the characteristics of the
new portable units that begin to rival the larger home units. The huge jump in
technology is illustrated by the effectiveness of the Inogen G3 and the about
to be released VBox Trooper. Innovation started with Inogen One G3 and AirSep's
LifeStyle are the less-than-10-pound battery-operated concentrator. AirSep has
re-engineered the unit down to a 2 pound device.
Newer portable oxygen concentrators can be used as multipurpose
devices.
Oxygen concentrator technology has been instantiated many times
over, but in a most compelling manner by Inogen as the Inogen oxygen concentrator
which represents a technological breakthrough. The Inogen One G3 is a complete
departure from current mainstream technologies. It represents a shift away from
standard large, bulky, stationary concentrator systems and inefficient, heavy,
and impractical portable devices.
This transformation presents a new opportunity for people who
make PSA oxygen equipment. Economies of scale and a new distribution modality
leveraging homecare services are set to change the medical oxygen industry.
Home delivery markets tend to be evaporating.
Delivering oxygen cylinders costs money and consumes resources.
In current competitive bidding markets, reimbursement for oxygen is down by up
to a third. Providers in these markets are compensating for this reduction by
moving their oxygen business to a non-delivery model.
Philips medical chronic disease equipment is able to address
market trends. Invacare has been a continuing market leader in articulating the
benefits of homecare.
The complexion of the home oxygen market is changing as portable
concentrators evolve to be smaller and less expensive. The advent of reliable,
inexpensive portable home oxygen concentrators has changed the market dynamic
significantly.
The market for oxygen concentrators is being disrupted by the
portable devices that can be used to provide oxygen under all circumstances.
The reimbursement is too low to support what worked in the past. This is a
dramatic shift in the home medical oxygen market.
The move from a primary delivery with a cost structure that
accounts for truck rolls to a portable device market is set to bring dramatic
changes to the industry. For vendors that have relied on the distribution
network and financing the distribution network, their hold on the market has
shifted.
Oxygen concentrator markets at $242.5 million in 2012 are
anticipated to reach $1.9 billion dollars by 2019. Growth is a result of new
competitors in the market, demand for the smaller lighter technology by
patients, and the market need by for greater mobility support for older people.
To Buy
a Copy Of This Report:-
Companies Profiled
Market Leaders
·
Inogen
·
Longfian
·
Nidek
·
Philips
Respironics
·
Invacare
·
Drive
·
Chart
/ Caire / SeQual
·
Scitech
Devilbiss
·
Teijin
·
AirSep
·
O2Concepts
Oxlife
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
No comments:
Post a Comment